BR112015000232A8 - Método para a síntese de ?,d-dihidroxi-isoleucina, composto, kit e método para sintetizar uma amatoxina - Google Patents

Método para a síntese de ?,d-dihidroxi-isoleucina, composto, kit e método para sintetizar uma amatoxina

Info

Publication number
BR112015000232A8
BR112015000232A8 BR112015000232A BR112015000232A BR112015000232A8 BR 112015000232 A8 BR112015000232 A8 BR 112015000232A8 BR 112015000232 A BR112015000232 A BR 112015000232A BR 112015000232 A BR112015000232 A BR 112015000232A BR 112015000232 A8 BR112015000232 A8 BR 112015000232A8
Authority
BR
Brazil
Prior art keywords
synthesis
isoleucine
dihydroxy
amatoxin
kit
Prior art date
Application number
BR112015000232A
Other languages
English (en)
Other versions
BR112015000232A2 (pt
BR112015000232B1 (pt
Inventor
Lutz Christian
Mueller Christoph
Simon Werner
Original Assignee
Heidelberg Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heidelberg Pharma Gmbh filed Critical Heidelberg Pharma Gmbh
Publication of BR112015000232A2 publication Critical patent/BR112015000232A2/pt
Publication of BR112015000232A8 publication Critical patent/BR112015000232A8/pt
Publication of BR112015000232B1 publication Critical patent/BR112015000232B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/065General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for hydroxy functions, not being part of carboxy functions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/10General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using coupling agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

método para a síntese de y,b-dihidroxi-isoleucina, composto, kit e método para sintetizar uma amatoxina. a invenção refere-se a novos métodos para a síntese de um sínton para y,b-dihidroxi-isoleucina 1 (n° cas 55399-94-5] como bloco de construção para a síntese de amatoxinas, e para novos métodos para a síntese de amatoxinas utilizando tais blocos de construção.
BR112015000232-3A 2012-07-13 2013-07-12 Método para a síntese de gama, delta-dihidroxi-isoleucina, composto, kit e método para sintetizar uma amatoxina BR112015000232B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12005173.5 2012-07-13
EP12005173.5A EP2684865A1 (en) 2012-07-13 2012-07-13 Methods for synthesizing amatoxin building block and amatoxins
PCT/EP2013/002084 WO2014009025A1 (en) 2012-07-13 2013-07-12 Methods for synthesizing amatoxin building block and amatoxins

Publications (3)

Publication Number Publication Date
BR112015000232A2 BR112015000232A2 (pt) 2017-06-27
BR112015000232A8 true BR112015000232A8 (pt) 2022-08-23
BR112015000232B1 BR112015000232B1 (pt) 2022-09-06

Family

ID=48793164

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015000232-3A BR112015000232B1 (pt) 2012-07-13 2013-07-12 Método para a síntese de gama, delta-dihidroxi-isoleucina, composto, kit e método para sintetizar uma amatoxina

Country Status (25)

Country Link
US (1) US9676702B2 (pt)
EP (2) EP2684865A1 (pt)
JP (2) JP2015528799A (pt)
KR (1) KR102122575B1 (pt)
CN (1) CN104470891B (pt)
AU (1) AU2013289555B2 (pt)
BR (1) BR112015000232B1 (pt)
CA (1) CA2878081C (pt)
CY (1) CY1117950T1 (pt)
DK (1) DK2872479T3 (pt)
ES (1) ES2589306T3 (pt)
HK (1) HK1209723A1 (pt)
HR (1) HRP20160984T1 (pt)
HU (1) HUE029538T2 (pt)
IL (1) IL236129A (pt)
MX (1) MX361116B (pt)
NZ (1) NZ702752A (pt)
PL (1) PL2872479T3 (pt)
PT (1) PT2872479T (pt)
RU (1) RU2637924C2 (pt)
SG (1) SG11201500225WA (pt)
SI (1) SI2872479T1 (pt)
UA (1) UA116991C2 (pt)
WO (1) WO2014009025A1 (pt)
ZA (1) ZA201409384B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3215519A1 (en) 2014-11-06 2017-09-13 Novartis AG Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase
US10723766B2 (en) 2015-11-27 2020-07-28 Heidelberg Pharma Research Gmbh Derivatives of gamma-amanitin
EP3222292A1 (en) * 2016-03-03 2017-09-27 Heidelberg Pharma GmbH Amanitin conjugates
EP3452492A1 (en) 2016-05-05 2019-03-13 Novartis AG Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase
AU2017204125B1 (en) 2016-06-17 2017-10-26 Crispr Therapeutics Ag Compositions and methods for the depletion of cd117+ cells
AU2017204139B2 (en) 2016-06-17 2018-08-09 Magenta Therapeutics, Inc. Compositions and methods for the depletion of cells
BR112019012937A2 (pt) * 2016-12-23 2019-12-10 Heidelberg Pharma Res Gmbh novo conjugado de amanitina
US10576161B2 (en) 2017-01-20 2020-03-03 Magenta Therapeutics, Inc. Compositions and methods for the depletion of CD137+ cells
WO2019030173A1 (en) 2017-08-07 2019-02-14 Heidelberg Pharma Gmbh NOVEL METHOD FOR SYNTHESIZING AMANITINES
US11420971B2 (en) 2017-08-07 2022-08-23 Heidelberg Pharma Research Gmbh Method for synthesizing amanitins
US20210030887A1 (en) * 2017-08-18 2021-02-04 Sichuan Baili Pharmaceutical Co. Ltd. Non-natural amatoxin-type antibody conjugate
AU2018329066B2 (en) * 2017-09-08 2022-02-17 Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. Amanitin antibody conjugate
KR20190043031A (ko) * 2017-10-17 2019-04-25 한국화학연구원 아마톡신 유도체 및 이의 제조방법
EP3546447A1 (en) 2018-03-29 2019-10-02 Heidelberg Pharma GmbH Synthesis of (2s,3r,4r)-4,5-dihydroxyisoleucine and derivatives
EP3958908A1 (en) 2019-04-24 2022-03-02 Heidelberg Pharma Research GmbH Amatoxin antibody-drug conjugates and uses thereof
EP3792250A1 (en) * 2019-09-13 2021-03-17 Pure Bioorganics SIA Synthesis of alpha-amanitin and its derivatives
EP3994146A1 (en) * 2019-07-05 2022-05-11 Pure Bioorganics SIA Synthesis of a-amanitin and its derivatives
KR102092817B1 (ko) * 2019-08-22 2020-03-24 한국화학연구원 아마톡신 유도체 및 이의 제조방법
CN112552196B (zh) * 2020-11-23 2024-02-02 蚌埠丰原医药科技发展有限公司 一种制备赖氨匹林的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1585076A (en) * 1976-07-13 1981-02-25 Roche Products Ltd Peptides of phosphonic and phosphinic acids
DE4104024A1 (de) * 1991-02-09 1992-08-13 Merck Patent Gmbh Aminosaeurederivate
JPH0959228A (ja) * 1995-08-17 1997-03-04 Hokuriku Seiyaku Co Ltd 光学活性なアミノアルコール及びその製造方法
EP0934923B1 (en) * 1996-09-13 2003-04-02 Nippon Kayaku Kabushiki Kaisha Optically active erythro-3-amino-2-hydroxybutyric esters and process for preparing said esters
JPH11137291A (ja) * 1997-11-12 1999-05-25 Mori Sangyo Kk アマニチン類の製造法
JP2002516337A (ja) * 1998-05-22 2002-06-04 アボット・ラボラトリーズ ガン、関節炎および網膜症を処置するための抗血管形成薬
JP2003528072A (ja) * 2000-03-17 2003-09-24 ブリストル−マイヤーズ スクイブ ファーマ カンパニー マトリックスメタロプロテアーゼおよびTNF−αの阻害剤としての環状β−アミノ酸誘導体
BR0109968A (pt) * 2000-04-18 2003-05-27 Lilly Co Eli Processo para a preparação de lipìdeo ii
ES2371085T3 (es) 2006-05-27 2011-12-27 Faulstich, Heinz, Dr. Utilización de conjugados de amatoxinas o falotoxinas con macromoléculas para la terapia tumoral y de la inflamación.
MX2011010469A (es) 2009-04-08 2012-03-14 Deutsches Krebsforsch Radicales de enlace al objetivo, armados con amatoxina para el tratamiento del cancer.
AU2010234334B2 (en) 2009-04-08 2014-10-09 Deutsches Krebsforschungszentrum Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy

Also Published As

Publication number Publication date
KR102122575B1 (ko) 2020-06-12
US9676702B2 (en) 2017-06-13
BR112015000232A2 (pt) 2017-06-27
JP2015528799A (ja) 2015-10-01
CA2878081A1 (en) 2014-01-16
ES2589306T3 (es) 2016-11-11
DK2872479T3 (en) 2016-09-05
CN104470891B (zh) 2016-10-12
MX2015000479A (es) 2015-04-08
EP2872479B1 (en) 2016-06-08
HK1209723A1 (en) 2016-04-08
AU2013289555A1 (en) 2015-01-22
JP2018090610A (ja) 2018-06-14
IL236129A0 (en) 2015-02-01
PL2872479T3 (pl) 2016-12-30
PT2872479T (pt) 2016-08-23
EP2684865A1 (en) 2014-01-15
MX361116B (es) 2018-11-28
SI2872479T1 (sl) 2016-11-30
IL236129A (en) 2017-10-31
RU2637924C2 (ru) 2017-12-08
NZ702752A (en) 2017-04-28
ZA201409384B (en) 2015-12-23
US20150210628A1 (en) 2015-07-30
CA2878081C (en) 2021-01-26
RU2015104802A (ru) 2016-08-27
KR20150036444A (ko) 2015-04-07
WO2014009025A1 (en) 2014-01-16
AU2013289555B2 (en) 2017-10-05
BR112015000232B1 (pt) 2022-09-06
UA116991C2 (uk) 2018-06-11
HRP20160984T1 (hr) 2016-10-21
EP2872479A1 (en) 2015-05-20
CY1117950T1 (el) 2017-05-17
JP6560382B2 (ja) 2019-08-14
CN104470891A (zh) 2015-03-25
SG11201500225WA (en) 2015-02-27
HUE029538T2 (en) 2017-03-28

Similar Documents

Publication Publication Date Title
BR112015000232A8 (pt) Método para a síntese de ?,d-dihidroxi-isoleucina, composto, kit e método para sintetizar uma amatoxina
CY1123164T1 (el) Διεργασια για τη συνθεση ενος αναστολεα ινδολαμινης 2,3-διοξυγενασης
PH12018500408A1 (en) Bicyclic compounds as atx inhibitors
CU20180001A7 (es) Derivados de oxopiridina sustituidos y procesos para su preparación
BR112016029333A2 (pt) síntese de compostos de carbamoilpiridona policíclico
PH12015500263A1 (en) New bicyclic derivatives
UY36175A (es) 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas
UY33735A (es) Compuestos antivirales
CU20170164A7 (es) Compuestos n-tieno (2,3-d)pirimidinil-d-fenilalanina, método para preparar los mismos y composiciones farmacéuticas que los contienen
PH12018500409A1 (en) New bicyclic compounds as dual atx/ca inhibitors
EA201692193A1 (ru) Способы получения ингибитора jak1 и его новых форм
TR201900038T4 (tr) GPR6'nın tetrahidropiridopirazin modülatörleri.
EA201890752A1 (ru) Способ получения противогрибковых соединений
EA200900945A1 (ru) Новый способ синтеза агомелатина
EA201790983A1 (ru) Синтез копанлисиба и его дигидрохлорида
EA200900946A1 (ru) Новый способ синтеза агомелатина
NZ711192A (en) Process for making benzoxazepin compounds
MX2018007219A (es) Metodos para preparacion de compuestos heterociclicos de 1,3-benzodioxol.
MX2019013979A (es) Metodos para la preparacion de compuestos heterociclicos de 1,3-benzodioxol.
CL2017000484A1 (es) Compuestos de azetidiniloxifenilpirrolidina
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
EA200900943A1 (ru) Новый способ синтеза агомелатина
EA201590116A1 (ru) Способ получения замещенных триазолопиридинов
EA201691362A1 (ru) Способы получения конденсированных гетероциклических модуляторов ионных каналов
EA201590729A1 (ru) Производные 3,4-дизамещенного оксазолидинона и их применение в качестве ингибиторов кальцийактивируемых калиевых каналов

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/07/2013, OBSERVADAS AS CONDICOES LEGAIS

B25D Requested change of name of applicant approved

Owner name: HEIDELBERG PHARMA RESEARCH GMBH (DE)

B25G Requested change of headquarter approved

Owner name: HEIDELBERG PHARMA RESEARCH GMBH (DE)